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Letters to the
Prevalence of anticardiolipin and
antinuclear antibodies in an elderly
hospitalized population and mortality
after a 6-year follow-up
SIR—The prognosis linked to anticardiolipin (aCL)
positivity in an elderly population is not known. Studies
of healthy elderly people give conflicting reports [1,2]
but two recent studies did not find a significant age-
related increase in aCL antibodies [3,4]. The discrepant
results observed in aCL prevalence are not only due to
differences in subject selection but also to the various
methods used [5]. The situation is different in frail
elderly subjects where a prevalence of 18.7% was
recently found [4]. Here, we report a study in which
unselected elderly sick patients were included. The
relationship between aCL and clinical manifestations
was evaluated, a comparison with antinuclear anti-
bodies (ANA) prevalence determined and an analysis
made of whether the presence of aCL is associated with
survival after 6 years.
Screening for aCL and ANA was performed in 192
consecutive patients (133 women and 59 men, aged
70-99) admitted to a hospital geriatric unit between
July 1989 and March 1990 for various diseases. There
were no exclusion criteria. Diagnosis and ingestion of
drugs at the time of admission as well as present or past
histories of venous and thrombo-embolic diseases,
cerebral or coronary ischaemic events, cardiac valvular
abnormalities, infections, malignancies and thrombo-
cytopenia were recorded. No patient had systemic
lupus erythematosis or features of other connective
disease. At 6-year follow-up, a survival analysis of the
outcomes of aCL-positive patients as compared with a
sex- and age-adjusted Geneva control population was
performed (n = 8104).
Blood samples were obtained on admission. aCL (IgG
and IgM isotypes) was measured by ELISA. IgG and
IgM aCL concentrations are expressed in GPL and MPL
units, respectively (where 1 unit represents the binding
activity of 1 /*g/ml of affinity purified aCL antibody),
and cut-offs for positivity for IgG and IgM isotypes were
set at 5 GPL and 3 MPL [6]. Depending on aCL levels,
samples were classified as low (< 20 GPL, < 10 MPL),
medium (20-50 GPL, 10-30 MPL) or high positive
(> 50 GPL, > 30 MPL). It is important to report the titre
together with the isotype: IgG isotypes are more often
associated with clinical complications than IgM. ANA
were measured by immunofluorescence with Hep-2
cell line cultures. A 1/160 titre was considered to be
positive.
aCL was found in 21 patients (10.9%), 15 women
(11.3%) and six men (10.2%). The sex distribution of
positivity in this elderly population is different from
that in a younger population, where female aCL
positivity is prominent. Sixteen (10 women and six
men) had IgG, while six (all women) had IgM (one
woman having both isotypes). ANA were found in 61
patients (31.8%), 48 women (36%) and 13 men (22%).
In 35 patients the titre was 1/160, in 12 it was 1/320
and in 14 it was higher. Only five patients were positive
for both aCL and ANA. Strokes and cardiac valvular
abnormalities were more frequent in aCL-positive
patients. When three age-groups were considered
(70-79, 80-89 and 90-99 years), the prevalence of
aCL decreased (17, 10 and 7% respectively) whereas
the prevalence of ANA increased (22, 32 and 42%).
However, due to the relatively small number of patients,
no statistical significant difference could be demon-
strated (x2 for trend 2.3 for aCL and 3.42 for ANA,
/)>0.05). For neither autoantibody was any significant
association observed after splitting the data by sex.
The most interesting (and unexpected) finding was
that changes in aCL prevalence -with age showed the
opposite pattern than that of ANA: although statistically
not significant, the lowest prevalence (7-5%) was
observed in the 90-99-year group. It was therefore
tempting to postulate that aCL antibodies were
associated with disorders that, because of their high
morbidity and lethality, would account for the
decreased prevalence in old age. However, during the
6-year follow-up period there was no statistically
significant difference in survival between aCL-positive
patients and an age- and sex-adjusted Geneva popula-
tion. At least two subsets of aCL exist, a pathogenic one
and a non-pathogenic one [7]. At the time of the study
no measurements of anti-/32 GP1 or other antiprotein-
antiphospholipid antibodies were performed. It is
possible that the sum of two opposite trends (a
decrease of pathogenic aCL and an increase of non-
pathogenic aCL) could explain why, despite the
tendency to decrease with ageing, the prevalence of
aCL remains higher than that observed in the young
population.
This study indicates that ANA and aCL are frequent
findings in sick patients admitted to a geriatric hospital.
aCL per se did not seem to be linked with a decrease in
survival but a more precise characterization of the
various types of aCL should be performed before
inferring their prognostic significance.
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Inappropriate acute admissions from
nursing and residential homes
SIR—This •winter period we have seen an increased
number of acute admissions to this district general
hospital, and this seems to have been the case
throughout many units in the UK. A proportion of
referrals coming from nursing homes and, to a lesser
extent, residential homes in the area seem to be
inappropriate. We have recently completed the first
stage of an audit looking at admissions from nursing
and residential homes to the acute medical unit in May
and June 1996.
A similar project has been performed in Falkirk and
District Royal Infirmary (Age Ageing 1995; 25 (suppl.
1): 12). Of the 42 admissions to that hospital over
6 months from nursing homes, 13 were deemed
inappropriate: six patients requiring nursing care
only and five patients who died very soon after
admission. They have now introduced admissions
guidelines, with some benefit.
The data for our audit were taken from the case mix
system. Of 2698 acute admissions to the medical unit,
there were 297 admissions from nursing and residen-
tial homes (11% of the total). We were able to retrieve
170 patients' case notes and from these reduced the
figure for admissions from nursing and residential
homes to 111 (by excluding patients who were
admitted as day cases or outpatients, those who were
admitted to and discharged from the medical assess-
ment unit on the same day, those who were admitted to
non-medical specialties and those admitted outside the
allotted dates).
Of the 111 admissions, 33 came from residential
homes. Fifty-six nursing homes and 18 residential
homes were represented. The highest number of
admissions from a single residential home was eight
and the highest number from a single nursing home
was six. Seventy-four general practitioners had
requested these 111 admissions, the most from a
single general practitioner being six. The length of stay
varied from 1 day to over 20 days. Twenty patients had
a stay of 24 h or less: five of these were transferred to a
community hospital, five died and 10 returned to the
nursing home. There were seven patients with a length
of stay of 2 days: one of these went to a community
hospital and two died. Of the seven who stayed 3 days,
four died.
Those who died within the first 3 days usually died
from a terminal event on a background of chronic
neurological disease—for example, bronchopneumonia
in patients with multiple strokes, dementia or Parkin-
son's disease. Twenty-two patients were discharged
back to the nursing home within 3 days. These had
fairly trivial or self-limiting conditions—for example,
drowsiness related to excess neuroleptic drugs, mild
dehydration, self-limiting angina, seizures in patients
known to have epilepsy, constipation causing abdom-
inal pain, back pain and mild chest infections. Those
patients who transferred to the community hospitals
(seven in the first 4 days) usually had problems which
warranted further medical input.
Therefore, the King's Mill Centre had more admis-
sions to acute medical wards from nursing and
residential homes than did the Falkirk and District
Royal Infirmary.
Admissions from residential homes were probably
more appropriate as nursing care is not available there.
We feel that some of the admissions from nursing
homes were inappropriate. These include most of
those of patients who died within 3 days, of patients
with self-limiting conditions and of patients for whose
care a community hospital bed would have been more
appropriate.
We have discussed with officers of the hospital trust
how we might take this initial phase further. We
considered repeating the study prospectively, drawing
up some guidelines for admissions to medical wards or
creating an out-reach team involving a geriatrician and
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